Croucher, P., Shipman, C., Perry, M., Lippitt, J., Asosingh, K., van Beek, E., . . . Vanderkerken, K. (2001). Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma.
Cita Chicago Style (17a ed.)Croucher, P., et al. Osteoprotegerin Inhibits the Development of Osteolytic Bone Disease in Multiple Myeloma. 2001.
Cita MLA (9a ed.)Croucher, P., et al. Osteoprotegerin Inhibits the Development of Osteolytic Bone Disease in Multiple Myeloma. 2001.
Precaución: Estas citas no son 100% exactas.